Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Correction to: Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality

Subjects

The Original Article was published on 04 January 2019

Correction to: Molecular Psychiatry

https://doi.org/10.1038/s41380-018-0339-3

Following publication of this article, Benjamin M. Neale contacted the journal to request the addition of the following text to the ‘Conflict of Interest’ declaration: ‘B.N. is a member of the scientific advisory board at Deep Genomics and RBNC Therapeutics and a consultant for Camp4 Therapeutics, Takeda Pharmaceutical and Biogen’. In addition, the genetic correlation presented in the abstract should be rg = 0.29 rather than r2 = 0.29 and the discussion should estate that that winner’s curse could have led to an underestimation of the causal estimate, rather than an inflation. This has now been corrected in both the PDF and HTML versions of this article.

Author information

Affiliations

Authors

Consortia

Corresponding authors

Correspondence to María Soler Artigas or Marta Ribasés.

Additional information

The original article can be found online at https://doi.org/10.1038/s41380-018-0339-3.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Soler Artigas, M., Sánchez-Mora, C., Rovira, P. et al. Correction to: Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality. Mol Psychiatry (2021). https://doi.org/10.1038/s41380-021-01049-6

Download citation

Search

Quick links